MODN Model N Inc

Model N to Host Life Sciences Commercial and Pricing Innovation Forum in Vienna, Austria

Model N, Inc. (NYSE:MODN), the leading provider of cloud-based revenue management solutions to life sciences, technology and manufacturing companies, today announced it will host the Commercial and Pricing Innovation Forum on October 10-12, 2017, at the Palais Hansen Kempinski in Vienna, Austria. The Forum is designed to drive innovation among thought leaders from industry experts and pharmaceutical, medical device and technology companies.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170925006556/en/

Model N to Host Life Sciences Commercial and Pricing Innovation Forum Oct 10-12, 2017. (Photo: Busin ...

Model N to Host Life Sciences Commercial and Pricing Innovation Forum Oct 10-12, 2017. (Photo: Business Wire)

“The Life Sciences Commercial and Pricing Innovation Forum is designed to enable global pricing leaders to share best practices and to drive further innovation,” said Zack Rinat, founder, executive chairman & CEO of Model N. “We are excited to host this Forum to paint the role of Cloud technology in driving end-to-end pricing, tendering and market access.”

The Forum will bring together over 100 pharmaceutical and medical devices executives from around the globe to discuss emerging commercial-wide trends, recurring challenges faced by the industry and best practices in global pricing, tender and revenue management.

“Tender planning is top of mind for commercial and pricing teams in Life Sciences,” said Roman Irsiegler, senior marketing manager biosimilars at Pfizer. “I am delighted to join a panel on tender management during this forum, where I will zoom in on Biosimilars and present the perspective of a mature and sophisticated market where tender and contracts are essential to success.”

The two-day conference includes exclusive business cases, workshops and user discussion groups that will deliver actionable insights for pharmaceutical and medical devices executives involved with global pricing and commercial improvement programs.

Sessions include:

  • Global Pricing Strategy Throughout the Product Life Cycle
  • Innovative Contracting Models: pitfalls and critical success factors in various markets
  • Tender Management: the current state of Tendering in medical devices and pharmaceuticals, use of public data, Tender Planning, etc.
  • Market Access strategies in Emerging Markets: strategies for sustainable market access
  • Value-Based Health Care: enrich the understanding of value-based healthcare, its definition, barriers and opportunities
  • Sales Approach Transformation: from product to solution sales

For more information on the event agenda, speakers and registration, please visit the Forum’s site at www.modeln.com/CPIF2017.

About Model N

Model N is the leader in Revenue Management solutions. Driving mission critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com.

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

EN
26/09/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Model N Inc

 PRESS RELEASE

Model N Named in U.S. News & World Report’s 2024-2025 Best Companies t...

Model N Named in U.S. News & World Report’s 2024-2025 Best Companies to Work For Model N excelled as one of the top companies to meet employee needs. SAN MATEO, Calif., July 11, 2024 (GLOBE NEWSWIRE) -- , the global authority in rankings and consumer advice, has named Model N as one of the 2024-2025 . Model N was rated among top companies to work for on factors contributing to job seekers’ decision-making when choosing a workplace that best meets their needs. U.S. News & World Report Best Companies to Work For ratings analyze employee sentiment against factors such as quality of pay...

 PRESS RELEASE

Model N Introduces Two Cutting-Edge Data Solutions, Syndicated Custome...

Model N Introduces Two Cutting-Edge Data Solutions, Syndicated Customer Master and Formulary Compliance Revenue Optimization leader introduces new integrated data solutions that accelerate time to insight, improve decision making, and strengthen compliance for life sciences manufacturers. SAN MATEO, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- (NYSE: MODN), the leader in revenue optimization and compliance unveiled two new integrated data solutions that address critical business needs for life sciences manufacturers. Syndicated Customer Master and Formulary Compliance were designed in clo...

 PRESS RELEASE

Model N Named one of Fortune Media and Great Place to Work ® 2024 Best...

Model N Named one of Fortune Media and Great Place to Work ® 2024 Best Workplaces in the Bay Area Revenue optimization leader earns national recognition for a second year in a row SAN MATEO, Calif., June 10, 2024 (GLOBE NEWSWIRE) -- (NYSE: MODN) Great Place to Work® and Fortune Media have honored Model N as one of this year’s Best Workplaces in the Bay Area. This is Model N’s second consecutive year being named on this prestigious list. Earning a spot means that Model N has surpassed rigorous benchmarks, establishing itself as one of the best workplaces among companies headquartered in...

 PRESS RELEASE

Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare...

Model N Introduces New Rebate Enhancement, as Pharma Companies Prepare for Impact from the Inflation Reduction Act New Medicare Part D inflation rebate enhancement helps pharma manufacturers manage pricing reforms SAN MATEO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: MODN), the leader in revenue optimization and compliance has introduced a critical product enhancement that supports evolving compliance needs around the Inflation Reduction Act (IRA). The company has introduced a new Medicare Part D inflation rebate-per-unit, ensuring pharma manufacturers remain compliant with impend...

 PRESS RELEASE

Model N Announces Date of Second Quarter Fiscal Year 2024 Financial Re...

Model N Announces Date of Second Quarter Fiscal Year 2024 Financial Results SAN MATEO, Calif., May 02, 2024 (GLOBE NEWSWIRE) -- Model N, Inc. (NYSE: MODN), a leader in revenue optimization and compliance, plans to announce financial results for the second quarter fiscal year 2024 pre-market on Monday, May 6, 2024. Due to the Company’s pending acquisition by Vista Equity Partners that was announced on April 8, 2024, there will not be a conference call or live webcast to discuss the financial results. About Model N Model N is the leader in revenue optimization and compliance for pharma...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch